Publication & Citation Trends
Publications
0 total
Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro. OA
Cited by 18
Semantic Scholar
Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-Producing Bordetella pertussis in Children, Philadelphia 2007–2014 OA
Cited by 14
Semantic Scholar
Antimicrobial Susceptibility of Pertactin-producing and Pertactin-deficient Strains of B ordetella pertussis from 2007 to 2014 OA
Cited by 0
Semantic Scholar
The mouse intranasal challenge model for potency testing of whole-cell pertussis vaccines
Cited by 10
Semantic Scholar
In memoriam: John P. Quinn, MD. OA
Cited by 0
Semantic Scholar
Pertactin-negative variants of Bordetella pertussis in the United States. OA
Cited by 108
Semantic Scholar
Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States OA
Cited by 200
Semantic Scholar
Detection systems for carbapenemase gene identification should include the SME serine carbapenemase.
Cited by 41
Semantic Scholar
Research Topics
Antibiotic Resistance in Bacteria
(34)
Antibiotics Pharmacokinetics and Efficacy
(14)
Bacterial biofilms and quorum sensing
(11)
Pharmaceutical and Antibiotic Environmental Impacts
(9)
Bacterial Infections and Vaccines
(7)
Affiliations
Centers for Disease Control and Prevention
Johnson & Johnson (United States)
Howard Hughes Medical Institute
Janssen (Belgium)
Baylor College of Medicine